Uganda’s Integrated Community-Based HIV Service Delivery Model (ICSDM) is demonstrating compelling success in reversing high viral loads among people living with HIV, with a 74.5% viral load re-suppression rate across the regions where it has been piloted.
The model, rolled out in 2023, is now recognized as a transformational approach to HIV care, offering real progress toward epidemic control through decentralized, community-driven support.
The findings were shared on 30 April 2025 at Speke Resort Munyonyo, following a joint evaluation by the Ministry of Health and Makerere University School of Public Health, under the Monitoring and Evaluation Technical Support (METS) programme, with funding from PEPFAR.
“This model represents a crucial shift toward patient-centred care,” said Dr. Simon Muhumuza, Senior Technical Advisor for Health Systems Strengthening at Makerere University. “By bringing services directly to communities, we’re seeing real impacts where they matter most.”
The ICSDM specifically targets patients with unsuppressed viral loads, those most vulnerable to transmitting HIV and experiencing severe health complications. Traditionally, these individuals relied on facility-based services. However, the new model deploys trained community health workers to provide tailored support, follow-up care, and counseling closer to the patient’s home.
The model doesn’t replace facility-based treatment, but it bridges gaps by ensuring those struggling with adherence or access aren’t left behind.
“The programme specifically targets those with unsuppressed viral loads—the individuals most at risk of transmitting HIV and facing health complications,” explained Dr Robert Mutumba of the Ministry of Health’s AIDS Control Programme.
The evaluation covered four regions: Acholi, Rwenzori, Mubende, and Kayunga–Mukono. It involved 25 health facilities and 711 patient interviews, alongside record reviews conducted from October 2023 to May 2024.
The assessment found a national re-suppression average of 74.5% among individuals enrolled in the community-based Intensive Case Surveillance and Differentiated Models (ICSDM). Mubende stood out with a re-suppression rate of 93.8%, while the Rwenzori region accounted for the largest share of ICSDM enrollments at 64.4%.
Private non-profit facilities demonstrated the highest overall performance, achieving a 90% re-suppression rate. Notably, 90% of individuals with high viral loads were linked to community health workers, with 34.4% receiving targeted support through ICSDM follow-up.
“These findings show that when care is made accessible and personalized, patients respond positively—and outcomes improve,” said Dr Muhumuza.
The evaluation also marked a shift in research ownership, with Makerere University leading the process as part of its strategic plan to build local evaluation capacity.
“We noticed that most impact evaluations in Africa, including Uganda, are often led by external experts,” said Dr Rhoda Wanyenze, Dean of the School of Public Health. However, we have now built the capacity through our academic programmes to conduct rigorous evaluations locally, which is a critical part of our strategic plan 2025–2030. We welcome partners to engage with us.”
She also highlighted the enduring role of U.S. support in health system strengthening.
“The strong partnership between our school and the Ministry of Health, supported by the American people, is not only improving the health of Ugandans but grounding interventions in solid evidence,” she added.
Despite the strong performance, the evaluation surfaced several implementation challenges such as stigma that still discourages some patients from community-based follow-up, gaps in community health worker support, including training and supervision and the cost-effectiveness of the model.
Experts agreed that while the model is impactful, its success depends on sustained investment in the community health workforce, better integration with health systems, and continued monitoring.
Uganda’s community HIV model is more than a pilot; it’s a policy-ready approach with proven results in reducing viral load and supporting patients at the margins of care. By bringing health services to where people live, the ICSDM not only improves treatment outcomes but also builds trust, strengthens public health systems, and moves Uganda closer to its HIV control targets.